BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 159876)

  • 1. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.
    Hahn T; Levin S; Handzel ZT; Ashkenazi A; Chemke J; Shterk V
    Isr J Med Sci; 1979 Sep; 15(9):775-8. PubMed ID: 159876
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome.
    Cupples CG; Tan YH
    Nature; 1977 May; 267(5607):165-7. PubMed ID: 16073432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon.
    Gurari-Rotman D; Revel M; Tartakovsky B; Segal S; Hahn T; Handzel Z; Levin S
    FEBS Lett; 1978 Oct; 94(2):187-90. PubMed ID: 151636
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leukocyte migration in the presence of leukemia-associated antigens in children with Down's disease].
    Szigeti R; Révész T
    Orv Hetil; 1977 Aug; 118(33):1952-4. PubMed ID: 142230
    [No Abstract]   [Full Text] [Related]  

  • 5. T-lymphocyte function and sensitivity to interferon in trisomy 21.
    Epstein LB; Epstein CJ
    Cell Immunol; 1980 May; 51(2):303-18. PubMed ID: 6154538
    [No Abstract]   [Full Text] [Related]  

  • 6. Leucocyte migration in presence of leukaemia-associated antigens in children with Down's syndrome.
    Szigeti R; Révész T; Schuler D; Gerö-Ferencz E; Zsuráffy E
    Haematologia (Budap); 1976; 10(1):23-6. PubMed ID: 137841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte function and serum immunoglobulins in Down's syndrome.
    Rosner F; Kozinn PJ; Jervis GA
    N Y State J Med; 1973 Mar; 73(5):672-5. PubMed ID: 4265822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphocyte subpopulations in Down's syndrome].
    Mori M; Zaike Y; Takeda T
    Rinsho Ketsueki; 1986 Oct; 27(10):1829-33. PubMed ID: 2950258
    [No Abstract]   [Full Text] [Related]  

  • 10. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HL-A leucocyte system in Down's syndrome.
    Harris R; Timson J; Wentzel J
    Transplant Proc; 1969 Mar; 1(1):122-3. PubMed ID: 4257479
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining.
    Crossen PE; Morgan WF
    Hum Genet; 1980; 53(3):311-3. PubMed ID: 6154638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ampicillin on the response of human lymphocytes to PHA.
    Wojtulewicz-Kurkus J; Skopińska-Rózewska EU; Norwaczyk M; Podobińska I
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):361-8. PubMed ID: 7294972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lymphocytotoxins and lymphocyte responses to mitogens of Down syndrome person.
    Nishida Y; Akaoka I; Suzuki T; Kobayashi M; Maruki K
    Am J Ment Defic; 1981 May; 85(6):596-600. PubMed ID: 6455917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodeficiency in Down's syndrome: analysis by OKT monoclonal antibodies.
    Bertotto A; Gerli R; Fabietti G; Arcangeli CD; Bianchi S; Vaccaro R
    Thymus; 1984; 6(6):365-7. PubMed ID: 6084348
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of mitogen-induced lymphocyte DNA synthesis by human interferon of different origins.
    Miörner H; Landström LE; Larner E; Larsson I; Lundgren E; Strannegård O
    Cell Immunol; 1978 Jan; 35(1):15-24. PubMed ID: 620425
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immune response in patients with Down's syndrome.
    Szigeti R; Révész T; Schuler D
    Acta Paediatr Acad Sci Hung; 1974; 15(1):31-9. PubMed ID: 4277396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cellular immunity tests in children with Down's syndrome].
    Szigeti R; Révész T; Schuler D
    Orv Hetil; 1974 Sep; 115(38):2173-5. PubMed ID: 4277782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.